|
1
|
Parasher A: COVID-19: Current
understanding of its pathophysiology, clinical presentation and
treatment. Postgrad Med J. 97:312–320. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Abobaker A, Raba A and Alzwi A:
Extrapulmonary and atypical clinical presentations of COVID-19. J
Med Virol. 92:2458–2464. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu J, Deswal A and Khalid U: COVID-19
myocarditis and long-term heart failure sequelae. Curr Opin
Cardiol. 36:234–240. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Islam MT, Nasiruddin M, Khan IN, Mishra
SK, Kudrat-E-Zahan M, Riaz TA, Ali ES, Rahman MS, Mubarak MS,
Martorell M, et al: A perspective on emerging therapeutic
interventions for COVID-19. Front Public Health.
8(281)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kmietowicz Z: Covid-19: WHO recommends
baricitinib and sotrovimab to treat patients. BMJ.
376(097)2022.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Wu X, Deng KD, Li C, Yang Z, Hu H, Cai H,
Zhang C, He T, Zheng F, Wang H, et al: Cardiac involvement in
recovered patients from COVID-19: A preliminary 6-month follow-up
study. Front Cardiovasc Med. 8(654405)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fialek B, Pruc M, Smereka J, Jas R,
Rahnama-Hezavah M, Denegri A, Szarpak A, Jaguszewski MJ, Peacock FW
and Szarpak L: Diagnostic value of lactate dehydrogenase in
COVID-19: A systematic review and meta-analysis. Cardiol J.
29:751–758. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Malik P, Patel U, Mehta D, Patel N, Kelkar
R, Akrmah M, Gabrilove JL and Sacks H: Biomarkers and outcomes of
COVID-19 hospitalisations: Systematic review and meta-analysis. BMJ
Evid Based Med. 26:107–108. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate healthcare
interventions: Explanation and elaboration. BMJ.
339(b2700)2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of thequality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wan X, Wang W, Liu J and Tong T:
Estimating the sample mean and standard deviation from the
samplesize, median, range and/or interquartile range. BMC Med Res
Methodol. 14(135)2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bowden J, Tierney JF, Copas AJ and Burdett
S: Quantifying, displaying and accounting for heterogeneity in the
meta-analysis of RCTs using standard and generalised Q statistics.
BMC Med Res Methodol. 11(41)2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pan F, Yang L, Li Y, Liang B, Li L, Ye T,
Li L, Liu D, Gui S, Hu Y and Zheng C: Factors associated with death
outcome in patients with severe coronavirus disease-19 (COVID-19):
A case-control study. Int J Med Sci. 17:1281–1292. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ayten O and Saylan B: Retrospective
analysis of severe COVID-19 pneumonia patients treated with
lopinavir/ritonavir: A comparison with survivor and non-survivor
patients. S Afr J Infect Dis. 35(233)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sepulchre E, Pittie G, Stojkovic V,
Haesbroek G, Crama Y, Schyns M, Paridaens H, de Marchin J, Degesves
S, Biemar C, et al: Covid-19: Contribution of clinical
characteristics and laboratory features for early detection of
patients with high risk of severe evolution. Acta Clin Belg.
77:261–267. 2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bonetti G, Manelli F, Patroni A,
Bettinardi A, Borrelli G, Fiordalisi G, Marino A, Menolfi A,
Saggini S, Volpi R, et al: Laboratory predictors of death from
coronavirus disease 2019 (COVID-19) in the area of Valcamonica,
Italy. Clin Chem Lab Med. 58:1100–1105. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kumar H, Gupta P and Shakya S: Predictors
of mortality in patients of COVID-19 pneumonia in intensive care
unit: An observational study in a tertiary care hospital, Lucknow,
India. J Clin Diagnostic Res. 15:C11–C15. 2021.
|
|
20
|
Vidal-Cevallos P, Higuera-De-La-Tijera F,
Chávez-Tapia NC, Sanchez-Giron F, Cerda-Reyes E, Rosales-Salyano
VH, Servin-Caamaño A, Vázquez-Medina MU and Méndez-Sánchez N:
Lactate-dehydrogenase associated with mortality in hospitalized
patients with COVID-19 in Mexico: A multi-centre retrospective
cohort study. Ann Hepatol. 24(100338)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Snipelisky D, Johnson R, Prasad R, Lakhani
B and Ellington J: Characteristics and outcomes based on perceived
illness severity in SARS-CoV-2. South Med J. 113:618–622.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Qin W, Bai W, Liu K, Liu Y, Meng X, Zhang
K and Zhang M: Clinical course and risk factors of disease
deterioration in critically Ill patients with COVID-19. Hum Gene
Ther. 32:310–315. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhu Y, Du Z, Zhu Y, Li W, Miao H and Li Z:
Evaluation of organ function in patients with severe COVID-19
infections. Med Clin (Barc). 155:191–196. 2020.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
24
|
Yousaf MN, Sarwar S, Tarique S, Ahmed M
and Tahir H: Mortality in patients of COVID-19 infection:
Biochemical markers and its cut-off values for predicting outcome.
J Coll Physicians Surg Pak. 32:37–41. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang Z, Ye D, Wang M, Zhao M, Li D, Ye J,
Liu J, Xu Y, Zhang J, Pan W, et al: Clinical features of COVID-19
patients with different outcomes in Wuhan: A retrospective
observational study. Biomed Res Int. 2020(2138387)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Akdogan D, Guzel M, Tosun D and Akpinar O:
Diagnostic and early prognostic value of serum CRP and LDH levels
in patients with possible COVID-19 at the first admission. J Infect
Dev Ctries. 15:766–772. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kantri A, Ziati J, Khalis M, Haoudar A, El
Aidaoui K, Daoudi Y, Chikhaoui I, El Yamani K, Mouhaoui M, El
Bakkouri J, et al: Hematological and biochemical abnormalities
associated with severe forms of COVID-19: A retrospective
single-centre study from Morocco. PLoS One.
16(e246295)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Azizmohammadi S, Azizmohammadi S,
Dahmardeh S, Azargashb H, Shokouh SJH, Mohajeri-Iravani M, Mobasher
M, Soleiman-Meigooni S and Zabihi M: Analysis of 239 ordinary and
severe cases of COVID-19:Clinical features and treatment. Eur J
Transl Myol. 31(9579)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang D, Li R, Wang J, Jiang Q, Gao C, Yang
J, Ge L and Hu Q: Correlation analysis between disease severity and
clinical and biochemical characteristics of 143 cases of COVID-19
in Wuhan, China: A descriptive study. BMC Infect Dis.
20(519)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zheng F, Tang W, Li H, Huang YX, Xie YL
and Zhou ZG: Clinical characteristics of 161 cases of corona virus
disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci.
24:3404–3410. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fukushima K, Yamada Y, Fujiwara S, Tanaka
M, Kobayashi T, Yajima K, Tanaka K, Sekiya N and Imamura A:
Development of a risk prediction score to identify high-risk groups
for the critical coronavirus disease 2019 (COVID-19) in Japan. Jpn
J Infect Dis. 74:344–351. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang H, Xing Y, Yao X, Li Y, Huang J, Tang
J, Zhu S, Zhang Y and Xiao J: Retrospective study of clinical
features of COVID-19 in inpatients and their association with
disease severity. Med Sci Monit. 26(e927674)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Huang H, Song B, Xu Z, Jiao Y, Huang L,
Zhao P, Huang J, Zhou Z, Zhao Z, Tian J, et al: Predictors of
coronavirus disease 2019 severity: A retrospective study of 64
cases. Jpn J Infect Dis. 74:54–60. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gómez LC, Curto SV, Sebastian MBP, Jiménez
BF and Duniol MD: Predictive model of severity in SARS CoV-2
patients at hospital admission using blood-related parameters.
EJIFCC. 32:255–264. 2021.PubMed/NCBI
|
|
35
|
Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang
H, Xiong Y, Cheng Z, Gao S, Liang K, et al: Clinical
characteristics of refractory coronavirus disease 2019 in Wuhan,
China. Clin Infect Dis. 73:e4208–e4213. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang W, Ban Y, Wu YH, Liu JY, Li XH, Wu
H, Li H, Chen R, Yu XX and Zheng R: Epidemiological and clinical
characteristics of 65 hospitalized patients with COVID-19 in
Liaoning, China. World J Clin Cases. 9:2205–2217. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Feng X, Li P, Ma L, Liang H, Lei J, Li W,
Wang K, Song Y, Li S, Yang W and Yang C: Clinical characteristics
and short-term outcomes of severe patients with COVID-19 in Wuhan,
China. Front Med (Lausanne). 7(491)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wu Y, Lu C, Pan N, Zhang M, An Y, Xu M,
Zhang L, Guo Y and Tan L: Serum lactate dehydrogenase activities as
systems biomarkers for 48 types of human diseases. Sci Rep.
11(12997)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen XY, Huang MY, Xiao ZW, Yang S and
Chen XQ: Lactate dehydrogenase elevations is associated with
severity of COVID-19: A meta-analysis. Crit Care.
24(459)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Henry BM, Aggarwal G, Wong J, Benoit S,
Vikse J, Plebani M and Lippi G: Lactate dehydrogenase levels
predict coronavirus disease 2019 (COVID-19) severity and mortality:
A pooled analysis. Am J Emerg Med. 38:1722–1726. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Poggiali E, Zaino D, Immovilli P, Rovero
L, Losi G, Dacrema A, Nuccetelli M, Vadacca GB, Guidetti D,
Vercelli A, et al: Lactate dehydrogenase and C-reactive protein as
predictors of respiratory failure in CoVID-19 patients. Clin Chim
Acta. 509:135–138. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lei F, Liu YM, Zhou F, Qin JJ, Zhang P,
Zhu L, Zhang XJ, Cai J, Lin L, Ouyang S, et al: Longitudinal
association between markers of liver injury and mortality in
COVID-19 in China. Hepatology. 72:389–398. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Aloisio E and Panteghini M: Aspartate
aminotransferase in COVID-19: A probably overrated marker. Liver
Int. 41:2809–2810. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhang C, Shi L and Wang FS: Liver injury
in COVID-19: Management and challenges. Lancet Gastroenterol
Hepatol. 5:428–430. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Battaglini D, Lopes-Pacheco M,
Castro-Faria-Neto HC, Pelosi P and Rocco PRM: Laboratory biomarkers
for diagnosis and prognosis in COVID-19. Front Immunol.
13(857573)2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Stegeman I, Ochodo EA, Guleid F, Holtman
GA, Yang B, Davenport C, Deeks JJ, Dinnes J, Dittrich S, Emperador
D, et al: Routine laboratory testing to determine if a patient has
COVID-19. Cochrane Database Syst Rev. 11(CD013787)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Babapoor-Farrokhran S, Gill D, Walker J,
Rasekhi RT, Bozorgnia B and Amanullah A: Myocardial injury and
COVID-19: Possible mechanisms. Life Sci. 253(117723)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Evans PC, Rainger GE, Mason JC, Guzik TJ,
Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger
J, et al: Endothelial dysfunction in COVID-19: A position paper of
the ESC working group for atherosclerosis and vascular biology, and
the ESC council of basic cardiovascular science. Cardiovasc Res.
116:2177–2184. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chung MK, Zidar DA, Bristow MR, Cameron
SJ, Chan T, Harding CV III, Kwon DH, Singh T, Tilton JC, Tsai EJ,
et al: COVID-19 and cardiovascular disease: From bench to bedside.
Circ Res. 128:1214–1236. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Weckbach LT, Curta A, Bieber S, Kraechan
A, Brado J, Hellmuth JC, Muenchhoff M, Scherer C, Schroeder I,
Irlbeck M, et al: Myocardial inflammation and dysfunction in
COVID-19-associated myocardial injury. Circ Cardiovasc Imaging.
14(e12220)2021.PubMed/NCBI View Article : Google Scholar
|
